» Articles » PMID: 19945912

Validation of a New REM Sleep Behavior Disorder Questionnaire (RBDQ-HK)

Overview
Journal Sleep Med
Specialties Neurology
Psychiatry
Date 2009 Dec 1
PMID 19945912
Citations 95
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: There are limited screening instruments for diagnosis of REM sleep behavior disorder (RBD) and none for quantifying the severity of disease. We aimed to validate a 13-item self-reported RBD questionnaire (RBDQ-HK) for diagnostic and monitoring purposes.

Methods: Based on ICSD-II and our previous clinical and empirical work, the RBDQ-HK questionnaire was designed and administered in patients attending university-affiliated sleep clinic and psychiatric out-patient clinic, and subjects from the general population. ROC curve and exploratory factor analysis were employed to evaluate the scale, which had a score ranging from 0 to 100.

Results: One hundred and seven RBD patients [mean age 62.6 (15.5) years; male 70.1%] and 107 control subjects [mean age 55.3 (9.0) years, male 57.9%] completed the questionnaire. The diagnoses of all the study subjects were independently ascertained by clinical interview and PSG. RBD patients had a significantly higher total RBDQ-HK score [mean (s.d.): 32.1 (16.1), range 3-71] than the control group [9.5 (10.2), range 0-55] (p<0.005). The RBDQ-HK demonstrated robust psychometric properties with moderate sensitivity (82.2%), specificity (86.9%), positive predictive value (PPV; 86.3%), and negative predictive value (NPV; 83.0%), high internal consistency and test-retest reliability. Exploratory factor analysis revealed two components (dream-related and behavioral factors) that corresponded to the essential clinical features of RBD. The best cut-off for total score (range 0-100) was at 18/19 and the best cut-off for factor 2 (behavioral factors including sleep talking, shouting, limb movements and sleep-related injuries, range 0-70) was at 7/8.

Conclusions: The RBDQ-HK has satisfactory validity and reliability as a measure of clinical RBD symptoms and severity. It may serve as an effective tool for diagnosis and evaluation of the disease course to facilitate future clinical and research studies.

Citing Articles

Parkin characteristics and blood biomarkers of Parkinson's disease in WPBLC study.

He H, Xiong X, Zheng Y, Hou J, Jiang T, Quan W Front Aging Neurosci. 2025; 17:1511272.

PMID: 40078640 PMC: 11897490. DOI: 10.3389/fnagi.2025.1511272.


Accelerometry-derived features of physical activity, sleep and circadian rhythm relate to non-motor symptoms in individuals with isolated REM sleep behavior disorder.

Ophey A, Vinod V, Rottgen S, Scharfenberg D, Fink G, Sommerauer M J Neurol. 2025; 272(3):201.

PMID: 39934559 PMC: 11813973. DOI: 10.1007/s00415-025-12931-6.


Sleep-related drugs utilization and suicide behaviors: a population-based study in China.

Zhang Y, Liu B, Li K, Jia H, Shi H, Liu Y BMC Public Health. 2025; 25(1):199.

PMID: 39833756 PMC: 11744836. DOI: 10.1186/s12889-025-21443-x.


Validation of the International REM Sleep Behavior Disorder Study Group Symptoms Severity Scale (IRBD-SSS): a new tool to assess RBD clinical severity.

Fantini M, Postuma R, Puligheddu M, Rieu I, Venel E, Figorilli M J Neurol. 2024; 271(11):7264-7271.

PMID: 39327269 DOI: 10.1007/s00415-024-12702-9.


Pain, obesity, adenosine salvage disruption, and smoking behavior mediate the effect of gut microbiota on sleep disorders: results from network Mendelian randomization and 16S rDNA sequencing.

Li F, Zhang R, Li J, Liu Y, Zhang Z, Du L Front Microbiol. 2024; 15:1413218.

PMID: 39144232 PMC: 11322093. DOI: 10.3389/fmicb.2024.1413218.